U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2005
130
Name Type Language
CETEARETH-20
INCI  
INCI  
Preferred Name English
POLYOXYL 20 CETOSTEARYL ETHER
II   MART.   NF  
Common Name English
POLYOXYL 20 CETOSTEARYL ETHER [USP-RS]
Common Name English
PEREGAL O-20
Common Name English
CETEARETH 20 [VANDF]
Common Name English
CETEARETH 20
VANDF  
Common Name English
CETEARYL-20 [VANDF]
Common Name English
PEG-20 CETYL/STEARYL ETHER
Common Name English
CETEARYL-20
VANDF  
Common Name English
POLYOXYL 20 CETOSTEARYL ETHER [NF]
Common Name English
POLYOXYL 20 CETOSTEARYL ETHER [II]
Common Name English
POLYOXYL 20 CETOSTEARYL ETHER [MART.]
Common Name English
MACROGOL CETOSTEARYL ETHER 20 [EP IMPURITY]
Common Name English
Code System Code Type Description
DAILYMED
YRC528SWUY
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
FDA UNII
YRC528SWUY
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL2107949
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
RXCUI
1307046
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
EVMPD
SUB20440
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
CAS
68439-49-6
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
GENERIC (FAMILY)
RXCUI
1311619
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
ALTERNATIVE
SMS_ID
100000085531
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
RS_ITEM_NUM
1547801
Created by admin on Mon Mar 31 18:47:40 GMT 2025 , Edited by admin on Mon Mar 31 18:47:40 GMT 2025
PRIMARY
All of the following components must be present:
STEARETH-20
CETETH-20
Definition References
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966